Kinase-targeted cancer therapies: progress, challenges and future directions
Abstract The human genome encodes 538 protein kinases that transfer a γ-phosphate group from ATP to serine, threonine, or tyrosine residues. Many of these kinases are associated with human cancer initiation and progression. The recent development of small-molecule kinase inhibitors for the treatment...
Main Authors: | Khushwant S. Bhullar, Naiara Orrego Lagarón, Eileen M. McGowan, Indu Parmar, Amitabh Jha, Basil P. Hubbard, H. P. Vasantha Rupasinghe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-018-0804-2 |
Similar Items
-
Regulation and inhibition of MAP kinases
by: Kaoud, Tamer Saad Gabr
Published: (2013) -
Aurora kinase inhibitors: current status and outlook
by: Vassilios eBavetsias, et al.
Published: (2015-12-01) -
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification
by: Carrow I. Wells, et al.
Published: (2021-01-01) -
The multifaceted role of lemur tyrosine kinase 3 in health and disease
by: Angeliki Ditsiou, et al.
Published: (2021-09-01) -
Domain Bridging Interactions in the Allosteric Network for IIAGlc Inhibition of the Escherichia coli Glycerol Kinase
by: Acquaye, Edith Abena
Published: (2011)